.
MergerLinks Header Logo

Announced

Eris Lifesciences to acquire Oaknet Healthcare from Samara Capital for $85m.

Financials

Edit Data
Transaction Value£67m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Pharmaceuticals

India

Domestic

Private Equity

dermatology

Private

Pending

pharmaceutical company

Acquisition

Majority

Single Bidder

Friendly

Synopsis

Edit

Eris Lifesciences, a pharmaceutical company, agreed to acquire Oaknet Healthcare, one of the fastest growing pharmaceutical companies in India, from Samara Capital, a private equity firm in Mumbai, for $85m. "As Oaknet becomes part of the Eris Group, it provides us with a robust growth platform in the areas of dermatology and cosmetology," Amit Bakshi, Eris Lifesciences Chairman and Managing Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US